Bull Case

Revenue growth re-accelerates as demand normalizes and pricing holds, allowing SKBL to outgrow similarly leveraged peers despite its currently thin margin base.

Operating leverage improves from the low 3.4% TTM operating margin, lifting EBITDA conversion and narrowing the gap versus higher-margin direct peers.

Free cash flow turns positive as working-capital discipline and capex restraint offset the current negative FCF yield, reducing balance-sheet pressure.

Leverage eases through earnings growth rather than refinancing, improving net debt to EBITDA from 4.4x and lowering relative credit risk versus peers with similar capital structures.

Base Case

Demand remains stable but not strong, so SKBL grows roughly in line with peers while its 2.27x sales multiple stays supported by modest operating improvement.

Margins stay near current levels as pricing and cost inflation offset each other, leaving operating profit expansion limited versus better-margin competitors.

Cash generation remains constrained, but incremental EBITDA improvement keeps interest coverage above distress levels and avoids a near-term liquidity event.

Leverage stays elevated at around 4.4x net debt to EBITDA, which limits strategic flexibility and keeps valuation discounting in place versus stronger peers.

Bear Case

Demand softens or pricing weakens, causing revenue to lag peers and preventing the company from absorbing fixed costs across its operating base.

Low margins compress further from the already thin 3.4% operating margin, pushing EBITDA down and widening the gap versus more resilient competitors.

Negative free cash flow persists, forcing additional borrowing or asset sales and increasing financial strain given the current 1.7x interest coverage.

High leverage becomes binding if earnings slip, raising refinancing risk and making SKBL materially weaker than peers with stronger balance sheets.

Overall Score

SKBL’s forward profile is constrained by high leverage and thin margins, but modest operating improvement can still support a mid-range outcome versus peers.